Authors: IRIBARNEGARAY MFD BUELGA DS SANCHEZ MJG OTERO MJ FALCAO AC

Citation: Mfd. Iribarnegaray et al., CARBAMAZEPINE POPULATION PHARMACOKINETICS IN CHILDREN - MIXED-EFFECT MODELS, Therapeutic drug monitoring, 19(2), 1997, pp. 132-139

Authors: FALCAO AC DEGATTA MMF IRIBARNEGARAY MFD BUELGA DS GARCIA MJ DOMINGUEZGIL A LANAO JM

Citation: Ac. Falcao et al., POPULATION PHARMACOKINETICS OF CAFFEINE IN PREMATURE NEONATES, European Journal of Clinical Pharmacology, 52(3), 1997, pp. 211-217

Authors: OTERO MJ BUELGA DS VAZQUEZ MA BARRUECO M DOMINGUEZGIL A

Citation: Mj. Otero et al., APPLICATION OF POPULATION PHARMACOKINETICS TO THE OPTIMIZATION OF THEOPHYLLINE THERAPY, Journal of clinical pharmacy and therapeutics, 21(2), 1996, pp. 113-125

Authors: GARCIA MJ GAVIRA R BUELGA DS DOMINGUEZGIL A

Citation: Mj. Garcia et al., PREDICTIVE PERFORMANCE OF 2 PHENYTOIN PHARMACOKINETIC DOSING PROGRAMSFROM NONSTEADY STATE DATA, Therapeutic drug monitoring, 16(4), 1994, pp. 380-387

Authors: GONZALEZ ACA VALIN LO BUELGA DS SANCHEZ MJG BORBUJO JS CORRAL LM HURLE AD

Citation: Aca. Gonzalez et al., DOSAGE PROGRAMMING OF PHENOBARBITAL IN NEONATAL SEIZURES, Journal of clinical pharmacy and therapeutics, 18(4), 1993, pp. 267-270

Authors: BELLVER MJG SANCHEZ MJG GONZALEZ ACA BUELGA DS DOMINGUEZGIL A

Citation: Mjg. Bellver et al., PLASMA-PROTEIN BINDING-KINETICS OF VALPROIC ACID OVER A BROAD DOSAGE RANGE - THERAPEUTIC IMPLICATIONS, Journal of clinical pharmacy and therapeutics, 18(3), 1993, pp. 191-197